CNN's Scott Jennings Showed That This Dem Was Not Ready for Primetime
Did Donald Trump Call Into C-SPAN's Washington Journal? Here's What Happened.
America Is Back: Team USA Sweeps Canada to Take Home Gold in Milan
A Tale of Two Athletes
America Keeps Winning
San Fernando Valley Film Accountant Pleads Guilty to $2 Million Embezzlement Scheme
Gavin Newsom, Bernie Sanders Say They Don't Know How to Get Birth Certificates
Romanian Hacker Pleads Guilty in 2021 Breach of Oregon State Government Office
Chaos Erupts in Mexico After Elimination of Cartel Leader 'El Mencho'
Byron Donalds Blasts Zohran Mamdani Over ‘Impossible’ Free Bus and Grocery Store Plan
TSA PreCheck Still Active During Partial Government Shutdown
Arizona Advances Bill to Rename a Highway After Charlie Kirk. Will the State's...
Secret Service Kill Armed Man Who Broke Into Mar-a-Lago
An Ambitious Bible-Reading Plan
Family As Communion: Familiaris Consortio
Tipsheet

Media Outlets Openly Report That the FDA's Latest Decision Was Political

Media Outlets Openly Report That the FDA's Latest Decision Was Political

The Food and Drug Administration on Thursday approved the first over-the-counter birth control pill in the U.S.

In early 2024, Perrigo’s once-a-day Opill, a progestin-only pill, will be available at drug stores, supermarkets, and online.

Advertisement

“Today’s approval marks the first time a nonprescription daily oral contraceptive will be an available option for millions of people in the United States,” said Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research, on Thursday. “When used as directed, daily oral contraception is safe and is expected to be more effective than currently available nonprescription contraceptive methods in preventing unintended pregnancy.”

There is no age restriction on the pill, despite concerns over correct usage and possible health hazards associated with it.

Seventeen advisers to the FDA voted unanimously in May to make Opill available over the counter despite concerns the agency raised about data Perrigo submitted with its application, including a study showing that many participants reported taking more pills than they were dispensed. The company said it couldn’t explain the discrepancy.

The agency questioned whether younger people and people with limited literacy could follow the dosing directions and said researchers likely used methods that exaggerated positive results. Perrigo said standards met or exceeded those used in other studies exploring over-the-counter drug adherence. (WSJ)

Kristan Hawkins of Students for Life said the news should mean pro-choice advocates won’t need abortions anymore, according to their own arguments. 

Advertisement

Related:

FDA

Others pointed out that media reports are not hiding the fact that it was a political decision. 

Health experts, citing the pill’s lengthy record of safety and effectiveness, have pushed for a nonprescription pill for years, but their campaign took on new urgency after the Supreme Court last year struck down the fundamental right to abortion established by Roe v. Wade. (WaPo)

Since the Supreme Court overturned the national right to an abortion last year, the accessibility of contraception has become an increasingly urgent issue. (NYT)

Though the drug itself and the campaign for its approval go back decades, pressure on the Biden administration to approve a hormonal over-the-counter birth control option increased after the fall of Roe v. Wade last year. (Politico)


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement